5-fluorotryptamine has been researched along with salicylhydroxamic acid in 1 studies
| Studies (5-fluorotryptamine) | Trials (5-fluorotryptamine) | Recent Studies (post-2010) (5-fluorotryptamine) | Studies (salicylhydroxamic acid) | Trials (salicylhydroxamic acid) | Recent Studies (post-2010) (salicylhydroxamic acid) |
|---|---|---|---|---|---|
| 15 | 0 | 4 | 252 | 0 | 41 |
| Protein | Taxonomy | 5-fluorotryptamine (IC50) | salicylhydroxamic acid (IC50) |
|---|---|---|---|
| Myeloperoxidase | Homo sapiens (human) | 3 | |
| Thyroid peroxidase | Homo sapiens (human) | 1.2 | |
| Lactoperoxidase | Bos taurus (cattle) | 1.2 | |
| Alternative oxidase, mitochondrial | Trypanosoma brucei brucei | 5.93 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aldib, I; Dufrasne, F; Furtmüller, PG; Nève, J; Obinger, C; Prévost, M; Rousseau, A; Soubhye, J; Van Antwerpen, P; Vanhaeverbeek, M; Zouaoui Boudjeltia, K | 1 |
1 other study(ies) available for 5-fluorotryptamine and salicylhydroxamic acid
| Article | Year |
|---|---|
Evaluation of new scaffolds of myeloperoxidase inhibitors by rational design combined with high-throughput virtual screening.
Topics: Catalytic Domain; Databases, Chemical; Drug Design; Halogenation; Humans; Kinetics; Lipoproteins, LDL; Molecular Docking Simulation; Oxidation-Reduction; Peroxidase; Purines; Pyrimidines; Structure-Activity Relationship | 2012 |